HeartBeam
closing summary financial closed significant funding round of million to enable company to execute on upcoming milestones strong cash position provides runway to late strategic focus and progress adjusted strategic focus to enable timely delivery of breakthrough ambulatory products submitted a application to the food and drug administration for the system version set sub meeting with for version validation foundational study on detection of coronary artery occlusions published in advances added three strong members to the board of directors added as vice president of regulatory patent granted for cardiac detection with system | HeartBeam
Company
Deck Type
Deck date
August 2023
Slide
9 of 10
Similar slides by HeartBeam
Results
August 2023
Related slides by other companies
Mergers and Acquisitions
August 2022
Results
August 2023
Investor Presentation
August 2023
Results
May 2022
Other recent decks by HeartBeam
Results
November 2023
Investor Presentation
October 2023
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2023 Slidebook.io